Navigation Links
In troubled economic times, BioSquare 2009 successfully serves as business and innovation starter

Lyon, France, March 30, 2009 / b3c newswire / - The 2009 edition of the BioSquare business conference was held March 9-11 in Lyon. For three days, the 343 companies in attendance, including 11 big pharma companies, held some 2,500 business meetings. The conference created real dynamics in a difficult economic context by offering biotech and pharma company managers a solid chance to develop business opportunities, create partnerships and get acquainted with new technologies in booming biotech industries.

BioSquare 2009 geared to the biotech market and companies 

“For Biotech companies, the financing of innovation is essential, which may be quite a challenge in the current economic climate. Finding the right partners will be an even more critical factor of success. In just three days, BioSquare 2009 served as a place for business exchanges leading to international partnerships,” said Bernadette Guagliata, BioSquare’s CEO.
In order to maintain any kind of leadership in innovation during these difficult times, it is necessary to convince investors, to communicate knowledge and know-how effectively, to determine which sectors are most favourable in terms of growth, to set up strategic partnerships, and to know how to sign the right contract… By enabling biotech companies to get advice from renown experts in these key areas, through its thematic sessions, BioSquare has positioned itself as an event with high added value.
“With the ability to create synergies among the various technologies (high-tech, cleantech, biotech), to present young biotech companies, to cross-match information...BioSquare becomes a relevant business conference,” states Albin Jourda, CEO of Gallium Moore, a merger/acquisition consulting firm specialised in information technology, biotech and cleantech.

BioSquare 2009 sets up meetings, partnerships and businesses 

With more than 2,500 business meetings, the 343 biotech firms represented by more than 520 delegates turned BioSquare into an effective business and trade platform. 
On Tuesday alone, 11 pharmaceutical leaders including Johnson&Johnson, GSK, Bayer, Sanofi-Aventis and 20 Biotech companies including Ipsogen, Theregen, Biomay, Ascendis pharma– had the chance to expose their know-how and R&D programmes, with the evidence that their technologies need others to exist, grow and find the right market.
Gilles Rubinstenn, Managing Director of the Pierre-Gilles de Gennes Foundation, notes: “We got involved in preparing the thematic programme for BioSquare 2009 and we were especially satisfied with the return on this investment: The Foundation’s main objective is to bring the academic research sector together with innovative firms to set up projects with high added value. During these three days, 40 face-to-face meetings with biotech companies left us with 25 serious partnership prospects.”

BioSquare 2009 talks innovations and new applications for Biotech technologies  

For the 2009 edition’s scientific and strategic programme, BioSquare decided to give the floor to booming innovative industries like cleantech, stem cells and theranostics.
Regarding the workshop on theranostics, Marc Essodaigui, Vice President Marketing & Sales, Europe & Asia at Ipsogen, notes: “Theranostics as a concept has been around a long time but is coming into real applications now. A better understanding of diseases allows more targeted therapies; and these need increasingly high-performance diagnostic tools. The pharma industry and the biotechs are therefore working together, especially on cancer, where patient monitoring is essential and diagnostic tools have real benefit.” In the current economic situation, “The biotechs that have innovative diagnostic technologies have more of a trump card to play, especially in supporting pharma activity for clinical development,” he concludes.

BioSquare in 2010 

While fewer delegates attended the 2009 edition, activity remains strong. BioSquare 2009 shows that the biotechs are standing up to the crisis. “The continuous progress and discoveries in the field of biotechnology area - more than ever – opening new opportunities for Health, Agriculture, Energy-management and Pollution-control” As Bernadette Guagliata noted at the opening session, “This makes BioSquare even more important, because we can effectively and efficiently be a support, to optimise and stimulate the process of partnering and networking at an international level.”
BioSquare 2010 edition will be held in Switzerland in an entirely overhauled format for more effectiveness, more contacts and more deals...

Press contact

Frédéric Le Gall 
+33 (0)6 64 28 89 00

BioSquare Contact

Bernadette Guagliata

b3c newswire

Related biology news :

1. Hatchery fish outnumber wild chinook salmon in troubled fall run
2. Shark attacks decline worldwide in midst of economic recession
3. Capillary mats labor-saving, economical alternative to hand watering
4. Basic research critical to Americas economic recovery
5. Study says middle class coral reef fish feel the economic squeeze
6. First-ever socioeconomic study on coral reefs points to challenges of coastal resource management
7. Top scientific meeting urges coordinated response to economic and environmental crises
8. New studies find global warming will have significant economic impacts on Florida coasts
9. Economic value of insect pollination worldwide estimated at 153 billion euros
10. Book breaks new ground in the study of economics and forest threats management
11. Scripps study sets high economic value on threatened Mexican mangroves
Post Your Comments:
(Date:11/17/2015)... Paris from 17 th until 19 ... from 17 th until 19 th November 2015. ... invented the first combined scanner in the world which scans ... now two different scanners were required: one for passports and ... the same surface. This innovation is an ideal solution for ...
(Date:11/17/2015)... 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... sale of broadly enabling, pressure cycling technology ("PCT")-based sample ... announced it has received gross proceeds of $745,000 from ... (the "Offering"), increasing the total amount raised to date ... closings are expected in the near future. ...
(Date:11/12/2015)... Mass. , Nov. 12, 2015  Arxspan ... Institute of MIT and Harvard for use of ... discovery information management tools. The partnership will support ... both biological and chemical research information internally and ... will be used for managing the Institute,s electronic ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Neurocrine ... Kevin Gorman , President and CEO of Neurocrine ... Jaffray Healthcare Conference in New York ... encouraged to visit the website approximately 5 minutes prior ... software.  A replay of the presentation will be available ...
(Date:11/25/2015)... ... November 25, 2015 , ... A ... Black Aerospace Professionals (OPBAP) has been formalized with the signing of a Memorandum ... met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, November ...
(Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
Breaking Biology Technology: